STORM Therapeutics

STORM Therapeutics is a biotechnology company dedicated to developing novel therapies that inhibit RNA Modifying Enzymes (RME) for oncology and other diseases. More than 150 RNA modifications and approximately 300 RNA modifying enzymes have been reported, representing new therapeutic targets. STORM leverages its first-mover advantage to build a novel drug discovery and RNA analysis platform to identify new targets and a proprietary pipeline of first-in-class small molecule candidates, which may be used for oncology, inflammation, viral infections, and central nervous system diseases.